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  With the aim to apply a rapid analytic method of cell kinetics using in vitro BrdU labelling
and anti－BrdU monoclonal antibody to the clinical fields， we investigated the cell kinetics of 20
urogenital malignant tumors．
  The DNA synthesizing cells which take up BrdU in its nuclei can be detected so clearly， since
the labelling index （LI） is easily identified． The correlations between LI and age and with
histological grade and stage of 14 transitional cell cancers of urinary tract were investigated．
There was no correlation・ between LI and age． The LI of high grade groups （G2 ＆ G3） were
significantly higher than that of the low grade group （Gi） （p less than O．05）． Also between LI
of pTl group and pT3 group， there was a statistical significance （p less than O．05） and generally
LI tended te increase according to stage progression．
  Therefore， the cytokinetic data obtained from the before mentioned method can be utilized as
a useful marker for measuring malignant potentials of each tumor．
                             （Acta Urol． Jpn． 35： 1285－1290， 1989）





























選激 輝   醸壽蕊
Fig． 1． Photomici ographs of urogemtal mahgnant tumors stained immunohistochemically． （A） Bladder cancei， TCC， Gl （×400）．
   （B） Pelvic tumor， TCC， G3 （×400）． （C） Urethral tumor， SCC （×200）． （D） Malignant lymphoma， diffuse large cell













































Tab正e 1．Results of cgll kinetic analysis of urogenital malignant tumors．
LI； labelling index， GF； growth fraction， L； cell loss rate．
Pathological type Case No．Age／Sex LI（X） GF（％） L（器）
Bladder TCC， Gl
 tumor TCC． Gl
     TCC． Gl
     TCC， Gl
     TCC． G2
     TCC， G2
     TCC． G2
     TCC． G2
     TCC， G2＞3
     TCC， G3
Ureteral TCC， Gl
 tumor TCC． G3
     scc
Pelvic TCC． Gl





















































































17 50／F 22． 1 74 35
Malignant Large cell 18
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Fig． 2． Labelling index （LI） versus age， grade and stage in patients
    with transitional cell cancer of the urinary tract． Bar shows
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